In the context of autoimmune diseases, GM-CSF has shown differing immunomodulatory (in diabetes type I and Crohn’s disease) and immunostimulatory (in rheumatoid arthritis and multiple sclerosis) effects [39–42]. Here, CSF2 is linked to autoimmune disease.